BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31737639)

  • 1. Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.
    Blank A; Schenker C; Dawson H; Beldi G; Zlobec I; Lugli A
    Front Med (Lausanne); 2019; 6():247. PubMed ID: 31737639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
    Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
    Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
    Neppl C; Zlobec I; Schmid RA; Berezowska S
    Mod Pathol; 2020 May; 33(5):802-811. PubMed ID: 31796876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
    Jepsen RK; Klarskov LL; Lippert MF; Novotny GW; Hansen TP; Christensen IJ; Høgdall E; Riis LB
    Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
    Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
    Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
    Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
    Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
    Secinti IE; Ozgur T; Gursoy D; Dede I
    APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of tumor budding, desmoplastic reaction, and lymphocytic infiltration in patients with gastric adenocarcinoma.
    Yavuz A; Simsek K; Alpsoy A; Altunay B; Gedik EO; Unal B; Bassorgun CI; Tatli AM; Elpek GO
    World J Gastrointest Pathophysiol; 2024 Apr; 15(1):91237. PubMed ID: 38682027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant-treated rectal adenocarcinoma.
    Aherne S; Donnelly M; Ryan ÉJ; Davey MG; Creavin B; McGrath E; McCarthy A; Geraghty R; Gibbons D; Nagtegaal I; Lugli A; Kirsch R; Martin ST; Winter DC; Sheahan K;
    Histopathology; 2024 Apr; ():. PubMed ID: 38629323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Line Derived Xenograft Mouse Models Are a Suitable
    Georges LMC; De Wever O; Galván JA; Dawson H; Lugli A; Demetter P; Zlobec I
    Front Med (Lausanne); 2019; 6():139. PubMed ID: 31316988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Peritumoral and Intratumoral Budding in Colorectal Cancer.
    Pyo JS; Choi JE; Kim NY; Min KW; Kang DW
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes.
    Pour Farid P; Eckstein M; Merkel S; Grützmann R; Hartmann A; Bruns V; Benz M; Schneider-Stock R; Geppert CI
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer.
    Forse CL; Rahimi M; Diamandis EP; Assarzadegan N; Dawson H; Grin A; Kennedy E; O'Connor B; Messenger DE; Riddell RH; Kirsch R; Karagiannis GS
    Exp Mol Pathol; 2017 Aug; 103(1):94-100. PubMed ID: 28716573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study.
    Karamitopoulou E; Esposito I; Zlobec I; Insilla AC; Wartenberg M; Schaeffer DF; Kalloger S; La Rosa S; Sempoux C; Ramos Centeno I; Lohneis P
    Virchows Arch; 2021 Apr; 478(4):719-726. PubMed ID: 33330964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of peritumoural and intratumoural budding in intestinal-type gastric adenocarcinoma.
    Qi B; Liu L; Pan Y; Xu S; Li J
    Arab J Gastroenterol; 2020 Jun; 21(2):111-116. PubMed ID: 32423856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
    Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
    BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
    Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
    Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma.
    Meyer SN; Galván JA; Zahnd S; Sokol L; Dawson H; Lugli A; Zlobec I
    Hum Pathol; 2019 May; 87():18-27. PubMed ID: 30794893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.